Whole Network Accounting Compliance Ethics executive pay SOX strategy

 

Bristol-Myers Squibb pinged $515 million to settle fraud charges

Filed in archive Ethics by leon on October 1, 2007

drug.jpg

Drugs giant Bristol-Meyers Squibb and a former subsidiary have been hauled over the coals and forced to pay more than half a billion dollars to settle settle federal and state investigations for promoting an anti-psychotic drug, Ablify, for uses that were not approved by the US Food and Drug Administration and providing illegal inducements to doctors and other health care providers.

The inducements included consulting fees and all expenses paid trips to resorts to attend conferences. There were also allegations that Bristol-Myers Squibb was behind the submission of false or fraudulent claims to medicaidlinks, Medicare and other federal health programs.

You can read more about it in the news report from the Boston Herald or you can check the detail in the settlement agreement here.






Permalink: Bristol-Myers Squibb pinged $515 million to settle fraud charges
Tags: BristolMyers  Squib  Ablify  2007  bristol  myers+squibb  bristol+myers  settle+fraud 

Trackback: http://www.creative-weblogging.com/cgi-bin/mt-tb.pl/94420





RSSrss   | See all blog subscribe options
Google google   |   What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter
Grouptivity

Use the search to look for other interesting posts



 
  • Advertise with us

  • Learn more about our advertising options or email advertising - at - creative-weblogging.com or give us a call at +1 (650) 331 4900.




  • Other blogs in the same channel in the Creative Weblogging Network







 

Tagcloud: Accounting boards of directors Compliance corporate crime corporate governance corporate reputation Ethics events executive pay litigation markets regulators risk shareholder activism SOX Sponsored Blog strategy